Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VEGFA | P15692 | 2/20 | 1.00 |
| ▸ | PGF | P49763 | 2/20 | 1.00 |
| ▸ | PRKAA2 | P54646 | 1/20 | 1.00 |
| ▸ | FLT1 | P17948 | 1/20 | 0.91 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.89 |
| ▸ | PRKCG | P05129 | 3/20 | 0.89 |
| ▸ | PRKCB | P05771 | 3/20 | 0.89 |
| ▸ | PRKCA | P17252 | 3/20 | 0.89 |
| ▸ | PRKCH | P24723 | 3/20 | 0.89 |
| ▸ | PRKCI | P41743 | 3/20 | 0.89 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.89 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.89 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.89 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.89 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.89 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.79 |
| ▸ | SNCA | P37840 | 3/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Proanthocyanidin A2 SCHEMBL14273881 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL13285132 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL18350173 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A1 SCHEMBL1689429 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL15398842 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL981582 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL15394643 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL18214185 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL15399757 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 | |
| Proanthocyanidin A2 SCHEMBL29551197 | 1.00 | VEGFA (1.00) | VEGFAPGFPRKAA2FLT1PRKD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064839-A1 | COMPOSITIONS AND METHODS RELATED TO THE SIMULTANEOUS MANUFACTURE AND PURIFICATION OF FLAVOR AND FRAGRANCE MOLECULES | Natural Extraction Systems, LLC (US) | 2025-03-27 | — | — | WO | claimed |
| EP-4493552-A2 | COMPOSITIONS AND METHODS RELATED TO THE SIMULTANEOUS MANUFACTURE AND PURIFICATION OF FLAVOR AND FRAGRANCE MOLECULES | Natural Extraction Systems, LLC (US) | 2025-01-22 | — | — | EP | claimed |
| CN-118576788-B | Super-hydrophilic coating with anticoagulation and anti-inflammatory functions, preparation method and application | 四川大学 | 2024-12-20 | — | — | CN | claimed |
| CN-118576788-A | Super-hydrophilic coating with anticoagulation and anti-inflammatory functions, preparation method and application | 四川大学 | 2024-09-03 | — | — | CN | claimed |
| CN-117860664-A | Procyanidine injectable hydrogel and preparation method and application thereof | 安徽中医药大学 | 2024-04-12 | — | — | CN | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| CN-117018303-A | Surface hydrophilic coating of medical material and preparation method thereof | 江门市泰乐医疗科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| WO-2023178172-A2 | COMPOSITIONS AND METHODS RELATED TO THE SIMULTANEOUS MANUFACTURE AND PURIFICATION OF FLAVOR AND FRAGRANCE MOLECULES | Natural Extraction Systems, LLC (US) | 2023-09-21 | — | — | WO | claimed |
| WO-2022023960-A1 | METHODS OF TREATING AND PREVENTING CORONAVIRUS INFECTION AND DISRUPTING CORONAVIRUS REPLICATION | FUNDACIÓN UNIVERSITARIA SAN ANTONIO (UCAM) (ES) | 2022-02-03 | — | — | WO | claimed |
| US-20210146006-A1 | COMPOSITE CONTAINING COLLAGEN AND ELASTIN AS A DERMAL EXPANDER AND TISSUE FILLER | TRUELASTIN LABORATORIES, INC. | 2021-05-20 | — | — | US | claimed |
| US-6429202-B1 | ADMINISTERING COMPLEX WITH PHOSPHOLIPIDS TO PREVENT ATHEROSCLEROSIS AND MYOCARDIAL OR CEREBRAL INFARCTIONS; REDUCES FORMATION OF ARTERIAL PLAQUES | INDENA S.P.A. (IT) | 2002-08-06 | — | — | US | claimed |
| EP-0659402-B1 | Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals | INDENA SPA (IT) | 2002-03-13 | — | — | EP | claimed |
| CN-1330548-A | Phospholipid complexes of proanthocyanidin A2 for use as anti-atherosclerotic agents | INDANE S P A (IT) | 2002-01-09 | — | — | CN | claimed |
| EP-1140115-A2 | PHOSPHOLIPID COMPLEXES OF PROANTHOCYANIDIN A2 AS ANTIATHEROSCLEROTIC AGENTS | INDENA S.p.A. (IT) | 2001-10-10 | — | — | EP | claimed |
| EP-0694305-B1 | Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidins | INDENA SPA (IT) | 2001-02-28 | — | — | EP | claimed |
| WO-2000037062-A2 | PHOSPHOLIPID COMPLEXES OF PROANTHOCYANIDIN A2 AS ANTIATHEROSCLEROTIC AGENTS | INDENA S.P.A. (IT) | 2000-06-29 | — | — | WO | claimed |
| US-5665365-A | Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields | INDENA S.P.A. (IT) | 1997-09-09 | — | — | US | claimed |
| EP-0694305-A1 | Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidinis | INDENA S.p.A. (IT) | 1996-01-31 | — | — | EP | claimed |
| EP-0659402-A2 | Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals | INDENA S.p.A. (IT) | 1995-06-28 | — | — | EP | claimed |
| EP-0210785-B1 | PROCESS FOR OBTAINING PROANTHOCYANIDINE A2, PHARMACEUTICAL COMPOSITIONS AND THEIR THERAPEUTIC USE | IDB HOLDING S.p.A. (IT) | 1990-09-26 | — | — | EP | claimed |